Aller au contenu principal

Paris-Saclay Spring – Paris-Saclay's unmissable innovation event returns on 16 May!

Innovation Article published on 30 April 2024 , Updated on 10 May 2024

Come and meet Université Paris-Saclay on its stand at the Paris-Saclay Spring exhibition and find out all about its projects and start-ups. The event will take place on 16 May on the HEC Paris campus in Jouy-en-Josas (Essonne), and will bring together all the key players in innovation in the Paris-Saclay region, Europe's leading deeptech cluster.

Since 2018, all the key players in innovation, research, science and economic development in Paris-Saclay have come together once a year at Paris-Saclay Spring, to showcase the technological innovation and scientific excellence of this leading deeptech biocluster in Europe.

Université Paris-Saclay will be attending once again this year, on stand PS13 right at the heart of the show, in the Paris-Saclay village. It will be joined by its Graduate Schools, the École normale supérieure Paris-Saclay, the Institut d'Optique Graduate School, Université de Versailles - Saint-Quentin-en-Yvelines (UVSQ), the DATAIA artificial intelligence research institute, the EUGLOH European Alliance and the Université Paris-Saclay Foundation. The university's stand will also feature start-ups and innovation projects linked to Université Paris-Saclay.

Université Paris-Saclay, France's leading university and one of the world's Top 20, is demonstrating, with all its laboratories and its student and scientific communities, how its major role in innovation is providing answers to the challenges of today and tomorrow.

Awarded the France 2030 label in July 2023, Université Paris-Saclay is the leader of Université Paris-Saclay's University Innovation Cluster (PUI), which brings together 13 key players in the region's innovation ecosystem and 15 partners.


The university's stand will feature :

  • The 503, present from 1 pm to 5:30 pm

The Institut d'Optique Graduate School's entrepreneurial centre, is a business accelerator in the field of photonics. It is unique in that it brings together engineering students in the innovation-entrepreneurship (FIE) field of study and innovative technology companies. By sharing a number of resources, such as its Photonic FabLab, the 503 creates an ecosystem conducive to innovation and collaborative research.

  • CicaNeuro, present from 1 pm to 5:30 pm

A collaborative project between the Chemistry of Natural Substances team at the Biomolecules: Design, Isolation, Synthesis Laboratory (BioCIS – Univ. Paris-Saclay/National Centre for Scientific Research (CNRS)/Univ. Cergy-Pontoise) and the Institut du cerveau et de la moelle épinière (CNRS, French National Institute of Health and Medical Research (Inserm), Assistance Publique – Hôpitaux de Paris (AP-HP), Sorbonne Univ.). It aims to develop small molecules derived from natural substances, to treat neurodegenerative diseases such as Parkinson's.

  • DATAIA, present from 1 pm to 5:30 pm

The DATAIA Institute is Université Paris-Saclay’s AI research centre. It brings together over 1,000 researchers from 46 university laboratories.

  • Diagante, present from 8 am to 12:30 pm

Co-founded in 2020 by Cécile Chevalier, Virginie Lebidois, and Martin Rottman, medical biology specialist at Raymond Poincaré Hospital and professor of microbiology at UVSQ, grew out of the laboratory for infection and chronic inflammation (2I – Univ. Paris-Saclay/UVSQ/Inserm) and AP-HP. The start-up develops medical devices for in-vitro biological diagnostics, to improve the detection of infections and to simplify and speed up diagnosis. Its first product, TISSUtainer®, enables solid samples to be transported and stored, and preserves the vitality of bacteria for better extraction during analysis. This allows Diagante to deliver faster results and personalised medical care at lower cost.

A Grande École for careers in research and higher education, bringing together basic science, engineering, and humanities.

  • EUGLOH, présent de13h à 17h30 

Eugloh is an alliance for global health, coordinated by Université Paris-Saclay. It brings together 9 European universities for top-level education, combining teaching, research and facilities.

The Paris-Saclay Foundation supports all of the university’s activities in education, research, and innovation, through patronage, aiding it in its global ambition.

  • The Prometheus IHU, present from 8 am to 12:30 pm

Is a centre of scientific excellence dedicated to healthcare, and is supported by Université Paris-Saclay alongside UVSQ, the French Alternative Energies and Atomic Energy Commission (CEA) and AP-HP. Integrating research, education and care, it aims to halve the mortality and sequelae caused by sepsis within ten years. Sepsis is the body's disproportionate inflammatory response to infection. The creation of this first world-class institute puts France in a unique position for the development of new diagnostic tests and medicines enabling personalised, innovative care for patients suffering from sepsis.

A Grande École for engineering, it is a world leader in optics and photonics, renowned for its quality training and innovative research.

Founded in 2007 and represented by Philippe Auclair, with support from the Paris-Saclay Cancer Cluster, is developing, based on its degradable material, new delivery systems for innovative, breakthrough active ingredients (medical devices and combined products) in the form of calibrated microspheres that can be easily industrialised and injected. Thanks to its expert technology, the company is able to adjust the degradation and release times of several classes of drugs, thus addressing a number of unmet medical needs. Backed by six international patents, Occlugel is positioned as a major player in the healthcare market of tomorrow.

  • PhotonHub, present from 1 pm to 5:30 pm

A project led by the Institut d'Optique Graduate School, aims to create an integrated academic and industrial ecosystem in the Île-de-France region to promote and develop talent and skills, and accelerate innovation in photonics.

Is a project that has been funded by the French National Research Agency since 2020, through the "LABCOM - LEMM" programme. This project is the result of a collaboration between Pierre Blazevic, professor at UVSQ, and Jean-Paul Carta, co-director of CARTA-ROUXEL, an SME specialising in general precision mechanics. Both are members of the Handicap neuromusculaire: physiopathologie, biotechnologies et pharmacologie appliquées laboratory (END-ICAP – Univ. Paris-Saclay/UVSQ/Inserm). The project involves the development of an instrumented garment, with the aim of detecting and preventing musculoskeletal pain and disorders caused by the unsuitable movements and postures we tend to adopt on a daily basis.

Located across 5 campuses in the Yvelines area, UVSQ is a multidisciplinary university with over 200 courses supported by high-potential, innovative research.

To find out more about the programme for this event, visit: 

SPRING 50: 19 start-ups linked to Université Paris-Saclay will be at the event

Logo bleu et blanc de Spring 50

Each year, on the occasion of Paris-Saclay Spring, the Paris-Saclay ecosystem honours 50 start-ups from its territory by inviting them to take part in the event as part of Spring 50. This year, Université Paris-Saclay has 19 start-ups from its student and scientific communities among this selection of the brightest ideas of tomorrow.

Selected start-ups enjoy the following benefits:
• Access for two people to all Paris-Saclay Spring events on 16 May 2024, including business meetings;
• A 4 m2 exhibition stand in one of the themed villages;
• An exclusive workshop to share experience with the 2024 sponsor and the French Tech Paris-Saclay;
• An English communication and pitch coaching session;
• Media coverage and press relations as part of the announcement of the winning start-ups;  
• Free annual membership of French Tech Paris-Saclay, the ability to benefit from the French Tech Paris-Saclay logo and privileged contacts.
Among the 50 start-ups selected for SPRING 50, 25 will have the chance to pitch their business in English on 16 May 2024 live on the Paris-Saclay SPRING stage.
The start-ups selected in 2021, 2022 and 2023 at Spring 50 raised over €305 million. Spring 50 represents an undeniable opportunity to grow and promote your technologies!


The 19 start-ups linked to Université Paris-Saclay and winners of the 2024 edition of Spring 50 are:

  • AM3L, co-founded in 2023 by Hicham Maskrot, a CEA research engineer in the Service de Recherche en Matériaux et procédés Avancés (SRMA – Univ. Paris-Saclay, CEA), and Timothée Delacroix, alumnus of Université Paris-Saclay and graduate of a thesis carried out at CEA Paris-Saclay, AM3L draws on their expertise in innovative materials and processes. It designs, develops and markets customised 3D architectured materials solutions. It offers personalised solutions for shock absorption, advanced filtration and low-carbon energy applications. By combining state-of-the-art metal additive manufacturing with advanced surface engineering, AM3L products feature enhanced properties thanks to their multi-scale architectures and controlled porosity.
  • Auralip, co-founded in 2023 by Hicham Maskrot, a CEA research engineer in the Service de Recherche en Matériaux et procédés Avancés (SRMA – Univ. Paris-Saclay, CEA), and Timothée Delacroix, alumnus of Université Paris-Saclay and graduate of a thesis carried out at CEA Paris-Saclay, AM3L draws on their expertise in innovative materials and processes. It designs, develops and markets customised 3D architectured materials solutions. It offers personalised solutions for shock absorption, advanced filtration and low-carbon energy applications. By combining state-of-the-art metal additive manufacturing with advanced surface engineering, AM3L products feature enhanced properties thanks to their multi-scale architectures and controlled porosity.
  • Blue Bees Therapeutics, start-up founded in 2022 by Philippe Berthon (CEO) and from the Department for Drug and Health Technologies (MTS – Univ. Paris-Saclay, CEA, French National Research Institute for Agriculture, Food and Environment (INRAE)), and is supported by the Paris-Saclay Technology Transfer Acceleration Company (SATT). Biotech company Blue Bees Therapeutics aims to develop new immunotherapies useful in the treatment of cancers that escape current immunotherapies, in particular those known as "cold" tumours. This technology can be used as a stand alone drug or in combination with other immunotherapies for even more effective treatment of patients. 
  • CIRCLECHAIN, co-founded in 2023 by CentraleSupélec alumnus Philippe Ogier and Jean-Yves Orsel, CIRCLECHAIN is a trusted, collaborative platform for end-to-end traceability of waste, materials and reuse equipment, particularly aimed at the construction sector.
  • Dntech, founded in 2022 by Université Paris-Saclay alumnus Amandine Lancelot, and supported by Genopole, Dntech specialises in the detection of pathogens in the food industry, directly on the production line. It offers manufacturers a fast, reliable detection kit, as well as expertise throughout the process, with effective quality controls and food audits.
  • Edonia, co-founded in 2023 by three AgroParisTech alumni, Hugo Valentin (CEO), Pierre Mignon (COO) and Nicolas Irlinger (CTO), in collaboration with the Paris-Saclay Food and Bioproduct Engineering laboratory (Say Food – Univ. Paris-Saclay, INRAE, AgroParisTech) and supported by Food'InnLab and CentraleSupélec's accelerator 21st, Edonia is a sustainable food deeptech. This start-up is revolutionising the future of food by transforming microalgae into a highly nutritious, sustainable and delicious meat alternative, thanks to a technology developed in collaboration with AgroParisTech research units.
  • Exhalon, founded in 2024 as a collaboration between the UVSQ Faculty of Medicine and Hôpital Foch, and currently being incubated at IncubAlliance, has developed real-time breath analysis methods for the rapid and accurate detection of infectious diseases. 
  • HIGHCAST, co-founded in 2021 by two CentraleSupélec alumni, Vivien Robert (CEO) and Flore de Lasteryrie, and supported by CentraleSupélec's accelerator 21st, Highcast develops artificial intelligence that helps factories achieve over 10% savings on their electricity bills by optimising planning (production, maintenance, etc.).
  • Hybrogines, this start-up co-founded in 2020 by CentraleSupélec alumni Nicolas Le Barbier and Abdenassar Salem Hedada (COO), and Lény Farnault (CEO), aims to make access to space for small satellites reliable, affordable and eco-friendly. Hybrogines is developing a fast, precise and flexible orbital transfer vehicle (OTV) equipped with next-gen hybrid engines. Its innovative propulsion system and design based on the search for optimum technology make it a unique and competitive OTV.
  • NCODIN, this start-up was co-founded in 2023 by Francesco Maneggati (CEO) and Bruno Garbin (CTO), and grew out of the Centre for Nanosciences and Nanotechnologies (C2N – Univ. Paris-Saclay, CNRS, Univ. Paris-Cité) and supported by CentraleSupélec's accelerator 21st. NcodiN aims to develop a revolutionary optical interposer that will redefine system integration in high-performance computing processors and artificial intelligence. Its patented nano-optoelectronic devices, integrated on silicon, enable ultra-fast, energy-efficient die-to-die interconnections.
  • Opscidia, founded in 2019 by CentraleSupélec alumnus Sylvain Massip, Opscidia offers an intelligent platform that helps all professionals confronted with scientific articles to extract relevant information thanks to artificial intelligence that automatically analyses and processes these scientific texts. 
  • Peekcell, co-founded in 2023 by Université Paris-Saclay alumnus Hélène Malka-Mahieu (CEO), Antoine Droneau (COO) and Gwendoline Tallec (CTO), Peekcell screens for female cancers using a urine sample, via innovative biomarker analysis and artificial intelligence technology. The test is painless, non-invasive and ensures reliable detection.
  • Proteme, supported by Genopole and the Food'InnLab and co-founded in 2021 by AgroParisTech alumnus Paul Malfoy and Valentin Sabatet, Proteme is developing a natural food coating solution for fruit and vegetables that extends the shelf life of protected foods. Using natural defence mechanisms against biological attacks, this protection acts like a second skin for products and reduces their breathing.
  • Rewake, co-founded in 2023 by CentraleSupélec alumnus Paul Forget, and Alban Catoire, Rewake's mission is to revolutionise the way laboratories access lab equipment and instrumentation, while actively contributing to preserving the planet. It offers cheaper, refurbished equipment.
  • Rime Bioinformatics, Rime Bioinformatics, founded in 2021 by Université Paris-Saclay alumnus Guillaume Abriat (CTO) and Antoine Culot (CEO), is a biotechnology research and development company. It develops services to accelerate medical, agronomic and veterinary research into alternatives to antibiotics. These technologies offer a detailed view of bacterial and bacteriophage genomes. 
  • STH Biotech, a Genopole start-up co-founded in 2021 by Naomi Kaminsky and Héloise Mailhac, who came through the Pépite PEIPS network, STH BIOTECH is developing a unique biotechnological process to produce high-yield, low-cost cannabinoids. By offering a unique production platform, it provides reliable, pure active ingredients to help companies continue their search for breakthrough medicines.
  • TheraSonic, A CEA start-up founded in 2023 by Benoit Larrat, a researcher at NeuroSpin (Univ. Paris-Saclay/CEA), TheraSonic is a MedTech start-up offering a new medical device capable of increasing the passage into the brain of therapeutic agents treating diseases of the central nervous system (brain tumours, neurodegenerative diseases).
  • Vitropep, Vitropep, founded by Christophe Tarabout, an alumnus of Université Paris-Sud (now Université Paris-Saclay), after incubation in Genopole's Shaker programme in 2022, customises dissolving microneedle patches made from biomaterials and optimised for the transdermal delivery of biomolecules. The aim is to improve the quality of life of patients suffering from chronic diseases such as diabetes.
  • Zoe Care, Founded in 2022 by CentraleSupélec alumnus Thomas Saphir, Zoe Care aims to use technology to help the elderly age well, ensuring frail people can continue living at home. It uses artificial intelligence technology to analyse Wi-Fi radio signals, which detects falls and abnormal behaviour, sends out emergency alerts and analyses daily activity.

To find out more about Spring 50, visit: